Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages

Clinical Pharmacology and Therapeutics

Volumn 99, Issue 1, 2016, Pages 21-25

  Subbotina, E ^a   Koganti, S R K ^a   Hodgson Zingman, D M ^a   Zingman, L V ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BASE; CELL PENETRATING PEPTIDE; DENDRIMER; DYSTROPHIN; MORPHOLINE; MORPHOLINO OLIGONUCLEOTIDE; OLIGOMER; RNA; UNCLASSIFIED DRUG; VIVO MORPHOLINOS; DRUG CARRIER;

ARTICLE; BLOOD CLOTTING; BLOOD VISCOSITY; CONJUGATION; DEATH; DNA MODIFICATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE SILENCING; NONHUMAN; NUCLEIC ACID STRUCTURE; PRIORITY JOURNAL; RNA BINDING; RNA SEQUENCE; ANIMAL; BIOLOGICAL MODEL; DISEASES; DRUG EFFECTS; GENE TARGETING; GENETIC ENGINEERING; HUMAN; PREVENTIVE MEDICINE; PROCEDURES;

ANIMALS; DISEASE; DRUG CARRIERS; GENE EXPRESSION; GENE TARGETING; GENETIC ENGINEERING; HUMANS; MODELS, GENETIC; MORPHOLINOS; PREVENTIVE MEDICINE;

EID: 84955239512     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.276     Document Type: Article

References (5)

1. Stirchak, E.P., Summerton, J.E., Weller, D.D. Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages. Nucleic Acids Res. 17(15), 6129-6141 (1989).
2. Kole, R., Krieg, A.M. Exon skipping therapy for Duchenne muscular dystrophy. Adv. Drug Deliv. Rev. 87, 104-107 (2015).
3. Moulton, J.D., Jiang, S. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules. 14(3), 1304-1323 (2009).
4. Moulton, H.M. In vivo delivery of morpholino oligos by cell-penetrating peptides. Curr. Pharm. Des. 19(16), 2963-2969 (2013).
5. Koganti, S.R. et al. Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis. Mol. Ther. 23(4), 707-716 (2015).